Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/30/19 → 3/18/20 |
Funding
- ICON Clinical Research: $6,499.00
A Phase 3, Randomized, Open-Label Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Adults > 65 Years of Age with Prior Pneumococcal Vaccination
- Greenberg, Richard (PI)